Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | Director · Chairman | January 05, 2026 | January 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date January 05, 2026 · Filed January 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,154 |
Reported balance
After 2026-01-05 transaction · row 1
1 source rowRow 1 · 2026-01-05 · Exercise / conversion · Acquired 9,145 · Balance 20,154 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.23 · Expires 2026-01-05 | Direct | 0 |
Reported balance
After 2026-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-05 · Exercise / conversion · Disposed 9,145 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 76,095 |
Reported balance
Holding disclosure · report date 2026-01-05 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 76,095 F1: The reporting person disclaims beneficial ownership of these shares. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 7, 2026 22:39 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,145 | $0.00 Strike: $15.23 | $0.00 |
DisclosureSEC source: 0001008886-26-000008 · form4.xml · derivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,145 shares Expires 2026-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 22:39 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 9,145 | $15.23 | $139,278.35 |
DisclosureSEC source: 0001008886-26-000008 · form4.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:22 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 11,021 | $0.00 Strike: $17.34 | $0.00 |
DisclosureSEC source: 0001008886-25-000014 · form4.xml · derivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,021 Underlying: Common Stock · 11,021 shares Expires 2035-01-10 F1 · derivative.exercise_date: This option becomes fully exercisable on January 10, 2030. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:18 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,014 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001008886-25-000012 · form4.xml · derivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,014 shares Expires 2025-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:18 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 10,014 | $13.17 | $131,884.38 |
DisclosureSEC source: 0001008886-25-000012 · form4.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:10 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,904 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001008886-24-000024 · form4.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,904 shares Expires 2024-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:10 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 1,909 | $39.56 | $75,520.04 |
DisclosureSEC source: 0001008886-24-000024 · form4.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 995 Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 22:10 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 2,904 | $18.80 | $54,595.20 |
DisclosureSEC source: 0001008886-24-000024 · form4.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 20:36 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 45,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001008886-23-000036 · form4.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents a gift of shares to the Common Property Trust, which is an estate planning trust with an independent trustee. The gift was made for estate planning purposes. F1 · shares: Represents a gift of shares to the Common Property Trust, which is an estate planning trust with an independent trustee. The gift was made for estate planning purposes. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 22:48 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 4,909 | $0.00 Strike: $38.93 | $0.00 |
DisclosureSEC source: 0001567619-23-000524 · doc1.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,909 Underlying: Common Stock · 4,909 shares Expires 2033-01-04 F3 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2028. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:48 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,938 | $0.00 Strike: $14.50 | $0.00 |
DisclosureSEC source: 0001567619-23-000524 · doc1.xml · derivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,938 shares Expires 2023-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was previously reported as covering 3,646 shares at an exercise price of $52.42 per share, but was adjusted to reflect the stock dividend that occurred on May 22, 2013. F2 · shares: This option was previously reported as covering 3,646 shares at an exercise price of $52.42 per share, but was adjusted to reflect the stock dividend that occurred on May 22, 2013. F2 · derivative.underlying_shares: This option was previously reported as covering 3,646 shares at an exercise price of $52.42 per share, but was adjusted to reflect the stock dividend that occurred on May 22, 2013. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:48 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 10,938 | $14.50 | $158,601.00 |
DisclosureSEC source: 0001567619-23-000524 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2022 Filed Mar 1, 2023 23:03 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004078 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 76,095 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| May 20, 2022 Filed Mar 1, 2023 23:03 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-004078 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 83,095 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 22:07 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 4,523 | $0.00 Strike: $42.25 | $0.00 |
DisclosureSEC source: 0001567619-22-000749 · doc1.xml · derivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,523 Underlying: Common Stock · 4,523 shares Expires 2032-01-04 F1 · derivative.exercise_date: This option becomes fully exercisable on January 4, 2027. Read SEC document |
| December 29, 2021 Filed Feb 14, 2022 14:57 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003867 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,102 Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,949 | $0.00 Strike: $10.75 | $0.00 |
DisclosureSEC source: 0001567619-21-022532 · doc1.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,949 shares Expires 2022-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 5, 2017. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 7,596 | $40.07 | $304,371.72 |
DisclosureSEC source: 0001567619-21-022532 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,102 Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 14,949 | $10.75 | $160,701.75 |
DisclosureSEC source: 0001567619-21-022532 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Feb 14, 2022 14:57 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003867 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 102,095 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| August 31, 2021 Filed Feb 14, 2022 14:57 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003867 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 118,595 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| July 12, 2021 Filed Dec 27, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 10,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-022532 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 128,595 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:29 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 4,452 | $0.00 Strike: $42.92 | $0.00 |
DisclosureSEC source: 0001567619-21-000544 · doc1.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,452 Underlying: Common Stock · 4,452 shares Expires 2031-01-05 F3 · derivative.exercise_date: This option becomes fully exercisable on January 5, 2026. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:29 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,745 | $0.00 Strike: $9.14 | $0.00 |
DisclosureSEC source: 0001567619-21-000544 · doc1.xml · derivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,745 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 5, 2016 Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:29 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 17,745 | $9.14 | $162,189.30 |
DisclosureSEC source: 0001567619-21-000544 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Feb 11, 2021 21:39 UTC Amendment | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 17,745 | $9.14 | $162,189.30 |
DisclosureSEC source: 0001567619-21-003093 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The original Form 4 is being amended to correct the number of securities beneficially owned by the reporting person following the reported transaction to reflect two gift transactions made by the reporting person prior to the date of the reported transaction. The gift transactions have been separately reported by the reporting person on Form 5. Read SEC document |
| December 16, 2020 Filed Feb 11, 2021 21:37 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003091 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,004 Read SEC document |
| December 08, 2020 Filed Feb 11, 2021 21:37 UTC | NRC HEALTH NRC · Entity 5534 | GiftCommon Stock | 17,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003091 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,754 Read SEC document |
| October 28, 2020 Filed Nov 5, 2020 22:16 UTC | NRC HEALTH NRC · Entity 5534 | OtherCommon Stock | 11,403 | $52.54 | $599,113.62 |
DisclosureSEC source: 0001567619-20-018764 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,004 F1 · kind: Represents shares that became directly owned by the reporting person through a substitution of assets in a trust. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:50 UTC | NRC HEALTH NRC · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 2,904 | $0.00 Strike: $65.80 | $0.00 |
DisclosureSEC source: 0001567619-20-000712 · doc1.xml · derivative · entry 5 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,904 Underlying: Common Stock · 2,904 shares Expires 2030-01-03 F3 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2025. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:50 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,481 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001567619-20-000712 · doc1.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,481 shares Expires 2020-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 5, 2015. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:50 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 10,962 | $65.80 | $721,299.60 |
DisclosureSEC source: 0001567619-20-000712 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,601 Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 21:50 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 26,481 | $6.30 | $166,830.30 |
DisclosureSEC source: 0001567619-20-000712 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2019 Filed Jan 7, 2019 21:20 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,109 | $0.00 Strike: $8.12 | $0.00 |
DisclosureSEC source: 0001567619-19-000704 · doc1.xml · derivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,109 shares Expires 2019-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became fully exercisable on January 5, 2014. Read SEC document |
| January 07, 2019 Filed Jan 7, 2019 21:20 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 9,098 | $38.08 | $346,451.84 |
DisclosureSEC source: 0001567619-19-000704 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,082 Read SEC document |
| January 07, 2019 Filed Jan 7, 2019 21:20 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 20,109 | $8.13 | $163,486.17 |
DisclosureSEC source: 0001567619-19-000704 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:20 UTC | NRC HEALTH NRCI · Entity 5534 | GrantEmployee Stock Option (right to buy) · Derivative | 4,990 | $0.00 Strike: $38.30 | $0.00 |
DisclosureSEC source: 0001567619-19-000704 · doc1.xml · derivative · entry 14 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,990 Underlying: Common Stock · 4,990 shares Expires 2029-01-03 F12 · derivative.exercise_date: This option becomes fully exercisable on January 3, 2024. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 19:32 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 80 | $35.00 | $2,800.00 |
DisclosureSEC source: 0001140361-18-019522 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse & Daughter Jt Disclosed balance after: 0 F1 · ownership.direct: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,246 | Not disclosed Strike: $40.54 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 12 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,246 shares Expires 2027-01-04 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,524 | Not disclosed Strike: $34.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 11 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,524 shares Expires 2026-01-05 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,669 | Not disclosed Strike: $35.48 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 10 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,669 shares Expires 2025-01-06 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 266 | Not disclosed Strike: $34.15 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 9 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 266 shares Expires 2024-01-07 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 1,823 | Not disclosed Strike: $27.13 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 8 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 1,823 shares Expires 2023-01-07 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 2,491 | Not disclosed Strike: $21.50 | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · derivative · entry 7 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 2,491 shares Expires 2022-01-05 F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · derivative.exercise_date: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Tax withholdingCommon Stock | 1,799 | $33.55 | $60,356.45 |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 6 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,071 Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 3,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 5 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F3 · kind: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. F3 · price: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash, for each class B option, less the exercise price per share of the option and any applicable tax withholding. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 12 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 4 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse & Daughter Jt Disclosed balance after: 87 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · ownership.direct: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 12 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 3 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse & Daughter Jt Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · ownership.direct: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | GrantCommon Stock | 125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 2 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 139,095 F1 · security: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · ownership.direct: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 21:44 UTC | NRC HEALTH NRCIA/B · Entity 5534 | Disposition to issuerClass B Common Stock | 125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-18-018958 · doc1.xml · nonDerivative · entry 1 Hays Michael D. · CIK 0001053133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 F1 · kind: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F1 · price: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). F2 · ownership.direct: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.